title: Editorial Commentary: Stemming the Tide: Can New Approaches to HIV Treatment Reverse the Trend of Rising Drug Prices in the United States?
authors.affiliation: Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Serena P
authors.initials: SP
authors.lastname: Koenig
authors.affiliation: Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti Center for Global Health, Weill Cornell Medical College, New York, New York.
authors.forename: Jean W
authors.initials: JW
authors.lastname: Pape
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D014481:United States
chemical_list: D019380:Anti-HIV Agents
keywords: HIV; antiretroviral therapy; cost; cost-effectiveness